| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| STAT6-IN-3 |
|
371919-80-1 |
詳細(xì)
|
| Bleximenib oxalate |
|
2866179-95-3 |
詳細(xì)
|
| BMS-986365 |
|
2446928-30-7 |
詳細(xì)
|
| UH15-38 |
|
2540881-21-6 |
詳細(xì)
|
| 4-Di-1-ASP |
|
959-81-9 |
詳細(xì)
|
| GDC-0339 |
|
1428569-85-0 |
詳細(xì)
|
| GlyRS-IN-1 |
|
112921-11-6 |
詳細(xì)
|
| RO7185876 |
|
2226038-71-5 |
詳細(xì)
|
| cis-trismethoxy Resveratrol |
|
94608-23-8 |
詳細(xì)
|
| MLN4924 hydrochloride |
|
1160295-21-5 |
詳細(xì)
|
| Leukotriene D4 |
|
73836-78-9 |
詳細(xì)
|
| PF-06648671 |
|
1587727-31-8 |
詳細(xì)
|
| EIPA |
|
1154-25-2 |
詳細(xì)
|
| Sclerotiorin |
|
549-23-5 |
詳細(xì)
|
| Zuclopenthixol |
|
53772-83-1 |
詳細(xì)
|
| 5-Bromo-3-(3-((tert-butyldiphenylsilyl)oxy)-2,2-dimethylpropyl)-2-iodo-1H-indole |
|
2641451-43-4 |
詳細(xì)
|
| PI3K/Akt/mTOR-IN-2 |
|
2757804-89-8 |
詳細(xì)
|
| Benzenesulfonic acid, 2-hydroxy-3-methoxy-, potassium salt (1:1) |
|
859188-04-8 |
詳細(xì)
|
| Thalidomide-5-NH-PEG1-NH2 hydrochloride |
|
2863634-98-2 |
詳細(xì)
|
| Tetrahydrocorticosterone |
|
68-42-8 |
詳細(xì)
|
| A-967079 |
|
1170613-55-4 |
詳細(xì)
|
| Mutant IDH1-IN-2 |
|
1429176-69-1 |
詳細(xì)
|
| GSK2850163 |
|
2121989-91-9 |
詳細(xì)
|
| Etomoxir |
|
124083-20-1 |
詳細(xì)
|
| ZM 449829 |
|
4452-06-6 |
詳細(xì)
|
| Trimetrexate |
|
52128-35-5 |
詳細(xì)
|
| Olcegepant/BIBN-4096/BIBN 4096BS |
|
204697-65-4 |
詳細(xì)
|
| benzyl (S)-4-(5-(5-bromo-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-1H-indol-2-yl)-6-(1-methoxyethyl)pyridin-3-yl)piperazine-1-carboxylate |
|
2865162-09-8 |
詳細(xì)
|
| VH032-C7-amine hydrochloride |
|
2502189-41-3 |
詳細(xì)
|
|
|
2227608-08-2 |
詳細(xì)
|
| NMS-E973 |
|
1253584-84-7 |
詳細(xì)
|
| HS148 |
|
1892595-16-2 |
詳細(xì)
|
| Velagliflozin |
|
946525-65-1 |
詳細(xì)
|
| Spirapril Hydrochloride |
|
94841-17-5 |
詳細(xì)
|
| (2S,4S)-4-Acetoxy-3,4-dihydro-2H-pyran-2-yl]methyl Acetate |
|
13036-11-8 |
詳細(xì)
|
| BRACO19 trihydrochloride |
|
351351-75-2 |
詳細(xì)
|
| 1,4,5,6-Tetrahydro-1-phenyl-3-cyclopentapyrazoleacetic acid |
|
21484-52-6 |
詳細(xì)
|
| CCT241533 hydrochloride |
|
1431697-96-9 |
詳細(xì)
|
| Rp-cAMPS sodium salt |
|
142439-94-9 |
詳細(xì)
|
| QCA570 |
|
2207569-08-0 |
詳細(xì)
|
| MI-1061 |
|
1410737-34-6 |
詳細(xì)
|
| 1,1,2,2-Tetramethoxyethane |
|
2517-44-4 |
詳細(xì)
|
| ML334 |
|
1432500-66-7 |
詳細(xì)
|
| Tedatioxetine hydrobromide |
|
960151-65-9 |
詳細(xì)
|
| AVN492 |
|
1220646-23-0 |
詳細(xì)
|
| Porphobilinogen |
|
487-90-1 |
詳細(xì)
|
| ARV393 |
|
2851885-95-3 |
詳細(xì)
|
| (2R,4S,E)-4-(2-(3,4-Dihydroxyphenethoxy)-2-oxoethyl)-3-ethylidene-2-hydroxy-3,4-dihydro-2H-pyran-5-carboxylic acid |
|
113145-68-9 |
詳細(xì)
|
| Cytochalasin C |
|
22144-76-9 |
詳細(xì)
|
| SMER18 |
|
944153-47-3 |
詳細(xì)
|
| Sibirioside A |
|
173046-19-0 |
詳細(xì)
|
| 2-Chloro-4-methyl-5-(trifluoromethyl)pyridine |
|
780802-36-0 |
詳細(xì)
|
| CDK4/6-IN-2 |
|
1800506-48-2 |
詳細(xì)
|
| Cycloaspeptide A |
|
109171-13-3 |
詳細(xì)
|
| Diphenidol |
|
972-02-1 |
詳細(xì)
|
| Taltobulin intermediate-4 |
|
187345-37-5 |
詳細(xì)
|
| BRD-6929 |
|
849234-64-6 |
詳細(xì)
|
| CI13015 |
|
2706-28-7 |
詳細(xì)
|
| PF-06700841-TsOH |
|
2140301-96-6 |
詳細(xì)
|
| ALX-1393 |
|
949164-09-4 |
詳細(xì)
|
| 4'-CHLOROPROPIOPHENONE |
|
6285-05-8 |
詳細(xì)
|
| AMG-0347 |
|
946615-43-6 |
詳細(xì)
|
| CDK4/6-IN-15 |
|
2078047-99-9 |
詳細(xì)
|
| Thalidomide-5-NH-PEG3-NH2 hydrochloride |
|
2863635-01-0 |
詳細(xì)
|
| BRD0639 |
|
2760881-74-9 |
詳細(xì)
|
| PF-07208254 |
|
2573122-40-2 |
詳細(xì)
|
| NLRP3-IN-19 |
|
2238819-65-1 |
詳細(xì)
|
| CK1α degrader-1 |
|
2881012-96-8 |
詳細(xì)
|
| Bleximenib/Menin-MLL inhibitor 24 |
|
2654081-35-1 |
詳細(xì)
|
| RLY-4008 |
|
2549174-42-5 |
詳細(xì)
|
|
|
2607830-80-6 |
詳細(xì)
|
| Minnelide sodium |
|
1254702-87-8 |
詳細(xì)
|
| 2-(4-Chloro-3,5-dimethylphenoxy)acetic acid |
|
19545-95-0 |
詳細(xì)
|
| ADENYLOSUCCINIC ACID |
|
19046-78-7 |
詳細(xì)
|
| IRE1α kinase-IN-5 |
|
2771006-47-2 |
詳細(xì)
|
| (S)-2-((S)-2-((2S,3R)-2-((3R,8R,11R,14S,17S,20S,23S,29aS)-8-Acetamido-23-(benzo[b]thiophen-3-ylmethyl)-11,14,17-tris(3-guanidinopropyl)-4,4-dimethyl-20-(naphthalen-2-ylmethyl)-1,9,12,15,18,21,24-heptaoxohexacosahydro-2H-pyrido[2,1-g][1,2]dithia[5,8,11,14,17,20,23]heptaazacyclohexacosine-3-carboxamido)-3-hydroxybutanamido)-5-guanidinopentanamido)-3,3-dimethylbutanoic acid |
|
2717490-36-1 |
詳細(xì)
|
|
|
1926949-71-4 |
詳細(xì)
|
| FTO-IN-1 TFA |
|
2797619-81-7 |
詳細(xì)
|
| ACHN-975 TFA |
|
1410809-37-8 |
詳細(xì)
|
| 5-(N,N-Dimethyl)amiloride hydrochloride |
|
1214-79-5 |
詳細(xì)
|
| BBO-8520 |
|
2893809-51-1 |
詳細(xì)
|
| STAT6-IN-2 |
|
1355594-85-2 |
詳細(xì)
|
| Luteoskyrin |
|
21884-44-6 |
詳細(xì)
|
| Piliformic acid |
|
98985-76-3 |
詳細(xì)
|
| Misetionamide/GP-2250 |
|
856785-75-6 |
詳細(xì)
|
| GlcNAcstatin |
|
922163-64-2 |
詳細(xì)
|
| Diaporthein B |
|
577705-64-7 |
詳細(xì)
|
| lactoyl-CoA |
|
1926-57-4 |
詳細(xì)
|
| Sorivudine |
|
77181-69-2 |
詳細(xì)
|
| RGD Trifluoroacetate |
|
2378808-45-6 |
詳細(xì)
|
| KIN-3248 |
|
2750709-91-0 |
詳細(xì)
|
| 10,11-Dehydrocurvularin |
|
21178-57-4 |
詳細(xì)
|
| Lenalidomide-C5-NH2 |
|
2093388-45-3 |
詳細(xì)
|
| AZ12672857 |
|
945396-55-4 |
詳細(xì)
|
| benzyl (S)-4-(6-(1-methoxyethyl)-5-(4,4,5,5-tetram |
|
2641451-79-6 |
詳細(xì)
|
| benzyl 4-[5-bromo-6-[(1S)-1-methoxyethyl]-3-pyridyl]piperazine-1-carboxylate |
|
2641451-78-5 |
詳細(xì)
|
| Propanoic acid, 3-[(aminocarbonyl)amino]-2-methyl-, sodium salt (1:1) |
|
84796-57-6 |
詳細(xì)
|
| CP 96021 |
|
139401-43-7 |
詳細(xì)
|
| KTX-582 |
|
2573298-13-0 |
詳細(xì)
|
| MZ-101/GYS1-IN-2 |
|
2839908-40-4 |
詳細(xì)
|